Companies: 10,795·Total market cap: $144.5T
CEN Biotech, Inc.

CEN Biotech, Inc.

CENBFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6526
P/E Ratio—
52W High$0.0002
52W Low$0.00001
EarningsFinancialsRevenue

CEN Biotech, Inc. (CENBF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

CENBF · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2023
EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Mar 31, 2023
After Market Close
CENBF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2024$1.54$1.54$1.541
Q2 FY2024$1.34$1.34$1.341
Q1 FY2024$1.57$1.57$1.571
Q4 FY2023$2.09$2.09$2.091
Q3 FY2023$1.39$1.39$1.391
Revenue Estimates
PeriodLowConsensusHigh# Analysts
Q3 FY2024$0.0B$0.0B$0.0B1
Q2 FY2024$0.0B$0.0B$0.0B1
Q1 FY2024$0.0B$0.0B$0.0B1
Q4 FY2023$0.0B$0.0B$0.0B1
Q3 FY2023$0.0B$0.0B$0.0B1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Beat Rate0 / 1 quarters
Largest Move+0.00% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: CENBF ends December

CEN Biotech, Inc. (CENBF) most recently reported earnings on March 31, 2023 for Q1 FY2023, posting EPS of $-0.01 (in line with the analyst consensus of —). The next CENBF earnings date is expected around September 1, 2026.

Each quarter, investors track CENBF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CENBF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CENBF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

CENBF earnings · 4 questions

CEN Biotech, Inc.'s next earnings report is expected around September 1, 2026. CENBF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CENBF historically reports after market close (AMC).

CENBF earnings datewhen is CENBF earningsCENBF next earnings datewhen does CENBF report earningsCENBF earnings calendar

▸ Source: FMP · CEN Biotech, Inc. SEC filings · US GAAP · CEN Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026